Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A phase 1 study evaluating the neutralizing, vaccinal monoclonal antibody VIR-3434 in participants with chronic hepatitis B virus infection Proceeding/Conference:Journal of Hepatology | 2021 | 2 | ||
Preliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection Proceeding/Conference:Journal of Hepatology | 2021 | |||
Preliminary results of a Phase 2 study of VIR-2218, an X-targeting RNAi therapeutic, in patients with chronic hepatitis B: sub-analyses of HBeAg-negative and HBeAg-positive patients Proceeding/Conference:Hepatology International | 2021 | |||
Safety and antiviral activity of VIR-2218, an X-targeting RNAi therapeutic, in participants with chronic hepatitis B infection: week 48 follow-up results Proceeding/Conference:Journal of Hepatology | 2021 | 3 | ||
2018 | 11 |